Mohamad Makhzoumi

Muhamad Makhzoumi is a General Partner and Head of NEA?s Global Healthcare Investing practice, which typically accounts for $1.5 billion of investments every two to three years across healthcare services, healthcare IT, biopharma and medical devices. Mohamad?s personal investment practice is primarily focused on the healthcare services and healthcare information technology sectors where he is currently a Director of Aetion, American Pathology Partners, Bright Health, Collective Health, Comprehensive Pharmacy Services, Nuvolo, Paladina Health, Radiology Partners, Strive Health, and Welltok. Mohamad?s past investments include Bravo Health, CHG Healthcare, DaVita NephroLife, DSI Renal, Golden State Medical Supply, Long Term Care Group, ppoNEXT, U.S. Renal Care, and Vantage Oncology. Previously, Mohamad focused on growth equity investments at Summit Partners prior to which he worked with UBS Investment Bank where he concentrated on leveraged finance and sponsor-led transactions. Mohamad received a bachelor's degree, with distinction, from the University of Pennsylvania and is a Board Member of The National Venture Capital Association (NVCA).